What it is
Co-amoxiclav is a combination of amoxicillin (a beta-lactam antibiotic) and clavulanic acid (a beta-lactamase inhibitor). The combination broadens the spectrum to cover bacteria that produce beta-lactamase enzymes, which make plain amoxicillin useless.
It is one of the most prescribed antibiotics in primary care for mild to moderate community infections of the airways, urinary tract and skin. It comes in several strengths and formulations.
Mechanism of action
It works through:
- Amoxicillin: inhibition of bacterial cell wall synthesis (bactericidal)
- Clavulanic acid: it blocks the bacterial beta-lactamases that would destroy the amoxicillin
- Together: activity is restored against beta-lactamase-producing bacteria
At the counter
When to recommend it
- Respiratory infections (otitis, sinusitis, acute bronchitis)
- Some urinary infections, according to local guidelines or the culture result
- Skin and soft tissue infections (impetigo, mild cellulitis)
- Dental abscesses that are spreading
When not to
- Allergy to beta-lactams (penicillin, cephalosporins)
- Infectious mononucleosis (risk of rash)
- History of jaundice or liver damage with co-amoxiclav
- Suspected serious infection needing hospital care
Warnings
- Important Cross-allergy: patients allergic to penicillin can also be allergic to this. Check the history.
- Important C. difficile-associated (pseudomembranous) diarrhoea: rare but serious. Warn the patient about severe diarrhoea with blood.
- Caution Mild to moderate diarrhoea: very common, because the gut flora is wiped out. Recommend a probiotic.
- Caution Kidney failure: the dose needs adjusting when GFR is below 30 mL/min.
Pharmacokinetics
- Absorption
- Rapid absorption after oral administration. Bioavailability around 90%. Onset of action at 1–2 hours. Clavulanic acid is absorbed just as quickly.
- Distribution
- Wide distribution in body tissues. Good penetration into the lungs, ears and urinary tract. Moderate plasma protein binding (20%). It crosses the placenta.
- Metabolism
- Amoxicillin is barely metabolised; clavulanic acid is partly metabolised in the liver.
- Elimination
- Mainly renal (amoxicillin largely unchanged). Half-life of 1–1.5 hours.
Co-amoxiclav vs amoxicillin
| Aspect | Co-amoxiclav | Amoxicillin |
|---|---|---|
| Antibacterial spectrum | Broad (covers beta-lactamase) | Narrower |
| Activity against S. aureus | Good (if not MRSA) | Poor |
| Cost | Higher | Lower |
| Gastrointestinal tolerance | Slightly worse (clavulanic acid irritates) | Better |
| First-line indication | Infections at risk of beta-lactamase | Simple susceptible infections |
Co-amoxiclav if beta-lactamase production or resistance is suspected. Amoxicillin alone for a simple susceptible infection (and it is cheaper).
Self-assessment
Three questions. When you check your answers you will see the explanation for each one.
-
Clavulanic acid is a beta-lactamase inhibitor that protects amoxicillin from being destroyed by these bacterial enzymes. That restores activity against resistant bacteria.
-
Amoxicillin is a penicillin, so patients allergic to penicillin can react to it. It always needs a medical decision.
-
Diarrhoea is very common because the gut microbiota is disrupted. It is mild in most cases but worth warning about. Recommend a probiotic.
Training content. It does not replace the summary of product characteristics or clinical judgement.